RxDoctor Payments Data

Charles Bowling, MD

Family Medicine · Monett, MONPI 1538155338

Payments from drug & device makers

$197in general payments, 2019–2025

Across 11 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$51
  • AbbVie$35
  • Pfizer$22
  • Abbott$21
  • Lilly USA, LLC$20
  • Smith+Nephew$17
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$197100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$197 in reported general payments places this provider in the 40th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$87,610
Medicare patients
255
Services billed
1,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban218$171,837
JardianceEmpagliflozin134$123,767
IngrezzaValbenazine Tosylate11$93,189
OzempicSemaglutide73$90,570
Trelegy ElliptaFluticasone/Umeclidin/Vilanter123$86,687
TrulicityDulaglutide56$69,781
MounjaroTirzepatide43$63,451
LinzessLinaclotide90$55,477
XareltoRivaroxaban61$45,914
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,087$38,375
OxycontinOxycodone Hcl14$34,456
Combivent RespimatIpratropium/Albuterol Sulfate63$33,528
EntrestoSacubitril/Valsartan30$26,794
Invega SustennaPaliperidone Palmitate14$25,093
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen626$25,011

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$22$178,095242 claims
Lilly USA, LLCTrulicity, Mounjaro$20$133,23199 claims
AbbVieLinzess, Creon$35$70,805102 claims
AstraZenecaSymbicort$15$19,78767 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Monett

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →